Results 211 to 220 of about 1,665,397 (307)

sGC stimulator BAY 41‐8543 improves survival and ventricular function in a rat model of doxorubicin‐induced cardiomyopathy with nephrotic syndrome

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Anthracyclines such as doxorubicin (DOXO) remain a cornerstone of cancer therapy but are associated with a high risk of cardiotoxicity and subsequent heart failure (HF). Impairment of NO/soluble guanylyl cyclase (sGC)/cGMP pathway has been reported in anthracycline‐induced cardiomyopathy.
Olga Gawrys, Petra Škaroupková, Soňa Kikerlová, Zdeňka Vaňourková, Martina Hüttl, Olga Lenčová, Kasin Yadunandam Anandam, Svenja Stomberg, Sönke Behrends, Barbara Szeiffová Bačová, Matúš Sykora, Lisa Dietz, Peter Sandner, Luděk Červenka, Martin Štěrba   +14 more
wiley   +1 more source

White-coat and masked hypertension diagnoses in chronic kidney disease patients. [PDF]

J Clin Hypertens (Greenwich), 2020
Pereira H, Bonilha A, Barretti P, Silva R, Burgugi V, Dos Santos V, Cuadrado L.   +6 more
europepmc   +1 more source

Relationship Between Masked Hypertension Measured by Ambulatory Blood Pressure Monitoring and Left Ventricular Global Longitudinal Strain: A Retrospective Study. [PDF]

Int J Gen Med, 2021
Fu M, Hu X, Sun S, Yi S, Zhang Y, Feng Y, Zhou Y, Geng Q, Dong H.   +8 more
europepmc   +1 more source

Targeted delivery of the CB2 receptor agonist JWH‐133 via VCAM‐1‐functionalised nanoparticles attenuates atherosclerosis and reveals sex‐specific therapeutic outcomes

British Journal of Pharmacology, EarlyView.
Background and Purpose Atherosclerosis, a chronic inflammatory disease characterised by lipid accumulation and endothelial dysfunction, remains a leading cause of cardiovascular morbidity and mortality. While cannabinoid 2 (CB2) receptor agonists show therapeutic promise in preclinical studies, their systemic application is hindered by poor ...
Lucía Martín‐Navarro, Lucía Martín‐Banderas, Josefa Álvarez‐Fuentes, María Dolores Herrera‐González   +3 more
wiley   +1 more source

[May Measurement Month 2019: Screening Analysis In Spanish Community Pharmacies and Detection of Masked Hypertension]. [PDF]

Farm Comunitarios, 2023
Mera-Gallego I, Tous I Trepat S, Prats-Mas R, Molinero A, Fornos-Pérez JA, Andrés-Rodríguez NF.   +5 more
europepmc   +1 more source

A Specific tRNA Half, 3'tiRNA‐GlyGCC, Regulates Hypoxic Pulmonary Artery Smooth Muscle Cell Proliferation via Myrf‐Mediated Endoplasmic Reticulum Stress

Cell Proliferation, EarlyView.
A schematic diagram illustrating how 3′tiRNA‐GlyGCC promotes the endoplasmic reticulum stress (ERS) and proliferation in hypoxic pulmonary artery smooth muscle cells (PASMCs) by inhibiting the expression of myelin regulatory factor (Myrf), ultimately leading to pulmonary hypertension (PH).
Lixin Zhang, Xiaoyu Guan, Xiangrui Zhu, Yingying Hao, Ya Xu, Hao Yuan, Danni Gao, Hongxia Du, Jiayu Li, Weiwei Cao, Cui Ma, Xiaoying Wang   +11 more
wiley   +1 more source

Pulse wave velocity in white coat and masked hypertension. [PDF]

J Clin Hypertens (Greenwich), 2020
Pierdomenico SD, Coccina F, Madonna R.
europepmc   +1 more source

Socioeconomic status, environmental factors, and motor function in children with cerebral palsy

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To investigate the association between socioeconomic status and cerebral palsy (CP) motor function, adjusting for known clinical and candidate environmental risk factors, that is, air pollution and distance to a children's treatment center (CTC).
Hana F Alazem, Ewa Sucha, Richard J Webster, Michelle L Larin, Anna M McCormick, Darcy L Fehlings, CP‐NET Group, Craig Campbell, Jan Willem Gorter, Carolyn Hunt, Anita Jethwa, Anne Kawamura, Marie Kim, Ronit Mesterman, Dawa Samdup   +14 more
wiley   +1 more source

Efficacy of antihypertensive treatment for target organ protection in patients with masked hypertension (ANTI-MASK): a multicentre, double-blind, placebo-controlled trial. [PDF]

EClinicalMedicine
Huang JF, Zhang DY, An DW, Li MX, Liu CY, Feng YQ, Zheng QD, Chen X, Staessen JA, Wang JG, Li Y, ANTI-MASK Investigators.   +11 more
europepmc   +1 more source

Clinical Relevance of Masked Hypertension [PDF]

American Journal of Hypertension, 2006
openaire   +3 more sources